| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MEDP | Stock Option (Right to Buy) | Options Exercise | $0 | -4.35K | -53.56% | $0.00 | 3.77K | Aug 22, 2024 | Common Stock | 4.35K | $42.62 | Direct | F4 |
| transaction | MEDP | Stock Option (Right to Buy) | Options Exercise | $0 | -3.77K | -100% | $0.00 | 0 | Aug 23, 2024 | Common Stock | 3.77K | $42.62 | Direct | F4 |
| Id | Content |
|---|---|
| F1 | The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. |
| F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $390.00 to $392.055. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| F3 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $390.00 to $392.01. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| F4 | The option vested in full on May 16, 2019. |